发明名称 |
Compuestos derivados de 3-(3-(3,5-bis(trifluorometil)fenil)-1h-1,2,4-triazol-1-il)-hidrazida; composicion farmaceutica; procedimiento para preprar precursores; procedimiento para tratar; uso para tratar trastornos asociados a crm1 tal como trastorno proliferativo, inflamatorio, entre otros (divisional de solicitud n° 225-2014). |
摘要 |
The invention generally relates to nuclear transport modulators, e.g., CRM1 inhibitors, and more particularly to a compound represented by structural formula I: or a pharmaceutically acceptable salt thereof, wherein the values and alternative values for the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of structural formula I, or a pharmaceutically acceptable salt or composition thereof, e.g., in the treatment, modulation and/or prevention of physiological conditions associated with CRM1 activity. |
申请公布号 |
CL2015001257(A1) |
申请公布日期 |
2015.09.21 |
申请号 |
CL20150001257 |
申请日期 |
2015.05.11 |
申请人 |
KARYOPHARM THERAPEUTICS, INC. |
发明人 |
SHACHAM SHARON;SHECHTER SHARON;SANDANAYAKA VINCENT P.;MACCAULEY DILARA |
分类号 |
C07D249/08;A61K31/4196;A61K31/497;A61K31/498;A61K31/506;A61K31/5377;A61K31/55;A61P1/00;A61P11/00;A61P25/28;A61P27/02;A61P29/00;A61P31/12;A61P35/00;A61P37/00;A61P37/08;C07D401/12;C07D403/12;C07D409/12;C07D413/12 |
主分类号 |
C07D249/08 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|